PCM
AURA icon

Permanent Capital Management’s Aura Biosciences AURA Stock Holding History

Permanent Capital Management’s Portfolio AURA Stock Details AURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$443K Hold
62,369
– – 0.06% 105
2026
Q1 		$440K Sell
62,369
-13,495
-18% -$77.4K 0.07% 84
2025
Q4 		$413K Sell
75,864
-71,905
-49% -$427K 0.08% 91
2025
Q3 		$913K Buy
+147,769
New +$966K 0.17% 58
2024
Q2 		$903K Buy
+144,229
New +$1.06M 0.19% 56

Other funds holding AURA

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
FIS
FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Permanent Capital Management's AURA Position: Q2 2026 in Review

Permanent Capital Management held its Aura Biosciences (AURA) position steady in Q2 2026 at 62,369 shares worth $443K. The position accounts for 0.06% of the portfolio, ranked #105.

Permanent Capital Management first reported a position in AURA in Q2 2024 and has held it in 5 quarters since. The position peaked at $913K in Q3 2025. 146 funds tracked by Wall St. Rank hold AURA as of Q2 2026.

  • Permanent Capital Management held 62,369 shares of Aura Biosciences worth $443K as of Q2 2026.
  • Permanent Capital Management left its Aura Biosciences share count unchanged in Q2 2026.
  • Aura Biosciences made up 0.06% of Permanent Capital Management's portfolio in Q2 2026, its #105 holding.
  • Permanent Capital Management first reported a position in Aura Biosciences in Q2 2024 and has held it in 5 quarters since.
  • Permanent Capital Management's Aura Biosciences position peaked at $913K in Q3 2025.
  • 146 funds tracked by Wall St. Rank held Aura Biosciences as of Q2 2026.

Based on Permanent Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.